Citadel Advisors
HLTH

Citadel Advisors’s Nobilis Health Corp. HLTH Stock Holding History

Citadel Advisors’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-44,800
Closed -$45K – 10146
2018
Q3 		$45K Buy
44,800
+14,800
+49% +$14.5K ﹤0.01% 8824
2018
Q2 		$36K Buy
30,000
+11,400
+61% +$15.8K ﹤0.01% 8516
2018
Q1 		$31K Buy
+18,600
New +$27K ﹤0.01% 8049

Other funds holding HLTH

PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Citadel Advisors's HLTH Position: Q3 2019 in Review

Citadel Advisors sold out of Nobilis Health Corp. (HLTH) in Q3 2019, closing a stake of 54,667 shares — an estimated $8K sold.

Citadel Advisors first reported a position in HLTH in Q1 2016 and held it in 6 quarters. The position peaked at $82K in Q1 2018. 3 funds tracked by Wall St. Rank hold HLTH as of Q3 2019.

  • Citadel Advisors reported no remaining Nobilis Health Corp. position as of Q3 2019 after selling out during the quarter.
  • Citadel Advisors sold 54,667 Nobilis Health Corp. shares in Q3 2019, an estimated $8K.
  • Citadel Advisors first reported a position in Nobilis Health Corp. in Q1 2016 and held it in 6 quarters.
  • Citadel Advisors's Nobilis Health Corp. position peaked at $82K in Q1 2018.
  • 3 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q3 2019.

Based on Citadel Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.